Nω-Nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast
- 23 July 1991
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 200 (1) , 83-87
- https://doi.org/10.1016/0014-2999(91)90669-h
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- l‐Arginine and arginine analogues: effects on isolated blood vessels and cultured endothelial cellsBritish Journal of Pharmacology, 1990
- Regional haemodynamic changes during oral ingestion of NG‐monomethyl‐l‐arginine or NG‐nitro‐l‐arginine methyl ester in conscious Brattleboro ratsBritish Journal of Pharmacology, 1990
- Sodium nitroprusside potentiates the depressor response to the phosphodiesterase inhibitor zaprinast in ratsEuropean Journal of Pharmacology, 1990
- Nω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formationEuropean Journal of Pharmacology, 1990
- Pressor effect of NG-nitro-L-arginine in pentobarbital-anesthetized ratsLife Sciences, 1990
- Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY‐5445, vinpocetine and 1‐methyl‐3‐isobutyl‐8‐(methylamino)xanthineBritish Journal of Pharmacology, 1989
- Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscleEuropean Journal of Pharmacology, 1988
- Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries.Circulation Research, 1986
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976